NovaBridge Biosciences (NBP) Gains from Investment Securities (2017 - 2024)
NovaBridge Biosciences (NBP) has 7 years of Gains from Investment Securities data on record, last reported at -$12000.0 in Q4 2024.
- On a quarterly basis, Gains from Investment Securities fell 100.6% to -$12000.0 in Q4 2024 year-over-year; TTM through Dec 2025 was -$12000.0, a 98.51% increase, with the full-year FY2025 number at $28.4 million, up 257894.14% from a year prior.
- Gains from Investment Securities reached -$12000.0 in Q4 2024 per NBP's latest filing, down from $2.0 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for NBP hit a ceiling of $2.0 million in Q4 2023 and a floor of -$760049.5 in Q4 2020.
- A 5-year average of $220275.0 and a median of $4472.6 in 2021 define the central range for Gains from Investment Securities.
- Peak YoY movement for Gains from Investment Securities: surged 1782.2% in 2023, then plummeted 100.6% in 2024.
- Tracing NBP's Gains from Investment Securities over 5 years: stood at -$760049.5 in 2020, then skyrocketed by 102.76% to $20945.3 in 2021, then soared by 407.32% to $106259.3 in 2022, then soared by 1782.2% to $2.0 million in 2023, then tumbled by 100.6% to -$12000.0 in 2024.
- Business Quant data shows Gains from Investment Securities for NBP at -$12000.0 in Q4 2024, $2.0 million in Q4 2023, and $106259.3 in Q4 2022.